The introduction of second-generation antipsychotics and cognitive therapies for
schizophrenia over the past two decades generated considerable optimism about …

These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Context Although antipsychotic treatment has recently increased, little is known about how
this development has differentially affected the office-based care of adults and young people …

Schizophrenia is characterized by positive, negative, cognitive, disorganization, and mood
symptoms. Antipsychotics are the mainstay in the pharmacologic treatment of schizophrenia …

This study sought to determine the moderators in the treatment effect of repetitive
transcranial magnetic stimulation (rTMS) on negative symptoms in schizophrenia. We …

The primary objectives in the treatment of schizophrenia are to reduce the frequency and
severity of psychotic exacerbation, ameliorate a broad range of symptoms, and improve …

All currently available antipsychotic drugs are the dopamine D2 receptor antagonists and
are capable of producing extrapyramidal side‐effects (EPS). Anticholinergic drugs are …

Guidelines for schizophrenia treatment have been created in various countries and have
been translated and used in Japan as well. However, the available drugs and their …

Objectives We outline a two-stage heuristic account for the pathogenesis of the positive
symptoms of psychosis. Methods A narrative review on the empirical evidence of the liberal …

During the last three decades, an increasing understanding of the etiology,
psychopathology, and clinical manifestations of schizophrenia spectrum disorders, in …